| Recruiting | Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors NCT07443020 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 1 |
| Recruiting | Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease NCT07192900 | David Bartlett, MD | Phase 1 |
| Not Yet Recruiting | Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma NCT07131345 | National Cancer Center, China | Phase 1 / Phase 2 |
| Recruiting | Study of ISM6331 in Participants With Advanced/Metastatic Malignant Mesothelioma or Other Solid Tumors NCT06566079 | InSilico Medicine Hong Kong Limited | Phase 1 |
| Unknown | Phase 1 Study of UCMYM802 Injection in Mesothelin-positive Advanced Malignant Solid Tumors NCT06256055 | UTC Therapeutics Inc. | Phase 1 |
| Recruiting | A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma NCT06057935 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | A Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors NCT05538572 | Prelude Therapeutics | Phase 1 |
| Completed | A Study to Investigate 14C-bemcentinib in Healthy Male Subjects NCT06469138 | BerGenBio ASA | Phase 1 |
| Completed | Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothel NCT03678350 | Roswell Park Cancer Institute | Phase 1 |
| Terminated | Cabozantinib With Pemetrexed in Advanced Non-small Cell Lung Cancer, Urothelial Cancer and Malignant Mesotheli NCT04173338 | Augusta University | Phase 1 |
| Unknown | Study of Recombinant Human Anti-PD-1 Monoclonal Antibody in Patients With Advanced Tumours NCT03852823 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Unknown | IP3R Modulation by Cancer Genes in Mesothelioma NCT03558932 | KU Leuven | — |
| Recruiting | Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery NCT03007030 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso NCT02580747 | Chinese PLA General Hospital | Phase 1 |
| Completed | Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With NCT02349412 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | A Study of LY3023414 in Participants With Advanced Cancer NCT01655225 | Eli Lilly and Company | Phase 1 |
| Unknown | The Anti-CTLA-4 Monoclonal Antibody Tremelimumab in Malignant Mesothelioma NCT01655888 | Azienda Ospedaliera Universitaria Senese | Phase 2 |
| Completed | Rehabilitation by Effort for Patients With Advanced Bronchial Cancer NCT03684486 | University Hospital, Toulouse | N/A |
| Completed | Observational Prospective Analysis of Biological Characteristics of Mesothelioma Patients NCT02300883 | Armando Santoro, MD | — |
| Completed | Dendritic Cell Vaccination for Patients with Solid Tumors NCT01291420 | University Hospital, Antwerp | Phase 1 / Phase 2 |
| Completed | Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disea NCT01085630 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Unknown | A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma NCT01649024 | Azienda Ospedaliera Universitaria Senese | Phase 2 |
| Completed | S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery NCT00770120 | SWOG Cancer Research Network | Phase 2 |
| Withdrawn | Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease NCT00733252 | Case Comprehensive Cancer Center | — |
| Completed | Dasatinib in Treating Patients With Previously Treated Malignant Mesothelioma NCT00509041 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Remo NCT00541073 | Centre Oscar Lambret | Phase 2 |
| Unknown | Mesothelin and Osteopontin as Diagnostic Markers in Patients With Mesothelioma or Atypical Mesothelial Hyperpl NCT00899613 | University Hospital, Caen | — |
| Completed | Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma NCT00458913 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite NCT00897247 | Barbara Ann Karmanos Cancer Institute | — |
| Completed | Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, Non-Sm NCT00398138 | Memorial Sloan Kettering Cancer Center | Phase 1 |
| Completed | Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma NCT00634205 | European Lung Cancer Working Party | Phase 2 |
| Completed | Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breas NCT00372840 | Fox Chase Cancer Center | N/A |
| Completed | Bortezomib in Treating Patients With Malignant Pleural Mesothelioma NCT00513877 | Cancer Trials Ireland | Phase 2 |
| Completed | Pemetrexed Disodium and Cisplatin Followed by Surgery With or Without Radiation Therapy in Treating Patients W NCT00334594 | Swiss Cancer Institute | Phase 2 |
| Terminated | Biomarkers of Angiogenesis and Disease in Patients With Unresectable Malignant Mesothelioma Treated on Clinica NCT00898547 | Alliance for Clinical Trials in Oncology | — |
| Completed | Pemetrexed Disodium and Cisplatin Followed By Surgery and Radiation Therapy in Treating Patients With Malignan NCT00227630 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Unknown | Combination Chemotherapy With or Without Surgery and Radiation Therapy in Treating Patients With Mesothelioma NCT00253409 | Institute of Cancer Research, United Kingdom | N/A |
| Completed | Active Symptom Control With or Without Chemotherapy in Treating Patients With Malignant Pleural Mesothelioma NCT00075699 | Medical Research Council | Phase 3 |
| Completed | Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma NCT00821860 | Papworth Hospital NHS Foundation Trust | Phase 3 |
| Completed | Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors NCT00066651 | National Cancer Institute (NCI) | Phase 1 |
| Completed | PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma NCT00053885 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Alanosine in Treating Patients With Cancer NCT00062283 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesoth NCT00354393 | The Cleveland Clinic | Phase 2 |
| Completed | Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma NCT00017186 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Terminated | Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma NCT00027508 | PharmaMar | Phase 2 |
| Unknown | Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer NCT00024271 | Herbert Irving Comprehensive Cancer Center | Phase 2 |
| Completed | Immunotoxin Therapy in Treating Patients With Advanced Cancer NCT00006981 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Capecitabine in Treating Patients With Malignant Mesothelioma NCT00004183 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Unknown | Palliative Therapy With or Without Chemotherapy in Treating Patients With Malignant Mesothelioma NCT00030459 | British Thoracic Society | Phase 2 |
| Completed | SU5416 in Treating Patients With Malignant Mesothelioma NCT00006014 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Inhaled Doxorubicin in Treating Patients With Advanced Solid Tumors Affecting the Lungs NCT00020124 | National Institutes of Health Clinical Center (CC) | Phase 1 |
| Completed | Combination Chemotherapy Before Surgery in Treating Patients With Mesothelioma of the Lung NCT00030745 | Swiss Cancer Institute | Phase 2 |
| Completed | Radiofrequency Ablation in Treating Patients With Refractory or Advanced Lung Cancer NCT00024076 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Completed | Cisplatin With or Without Pemetrexed Disodium in Treating Patients With Malignant Mesothelioma of the Pleura T NCT00005636 | Memorial Sloan Kettering Cancer Center | Phase 3 |
| Completed | Cisplatin With or Without Raltitrexed in Treating Patients With Malignant Mesothelioma of the Pleura NCT00004920 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Raltitrexed in Treating Patients With Malignant Mesothelioma That Cannot Be Surgically Removed NCT00004254 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 2 |
| Completed | Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the P NCT00019825 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma NCT00054002 | Roswell Park Cancer Institute | Phase 2 |
| Completed | S9810: Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot B NCT00003723 | SWOG Cancer Research Network | Phase 2 |
| Completed | Liposomal-Cisplatin Analogue (L-NDDP) in Treating Patients With Malignant Pleural Mesothelioma NCT00004033 | NYU Langone Health | Phase 2 |
| Completed | Radiation Therapy in Preventing Metastatic Cancer in Patients Who Have Diagnostic Procedures to Identify Malig NCT00006231 | University of Glasgow | Phase 3 |
| Completed | Vaccine Therapy in Treating Patients With Stage I, Stage II, or Stage IIIA Non-small Cell Lung Cancer or With NCT00003974 | Roswell Park Cancer Institute | Phase 1 |
| Unknown | Vaccine Therapy and Ganciclovir in Treating Patients With Mesothelioma NCT00006216 | Louisiana State University Health Sciences Center in New Orleans | Phase 1 |
| Unknown | ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesotheli NCT00003034 | Alfacell | Phase 3 |
| Completed | Cisplatin, Interferon Alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothe NCT00003263 | Fox Chase Cancer Center | Phase 1 |
| Terminated | Antineoplaston Therapy in Treating Patients With Advanced Mesothelioma NCT00003508 | Burzynski Research Institute | Phase 2 |
| Completed | Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors NCT00002608 | Ottawa Regional Cancer Centre | Phase 2 |
| Completed | Collecting Tumor Samples From Patients With Gynecological Tumors NCT00897442 | Gynecologic Oncology Group | — |
| Completed | Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer NCT00002475 | St. Vincent Medical Center - Los Angeles | Phase 2 |
| Unknown | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma NCT00002465 | St. Vincent Medical Center - Los Angeles | Phase 1 / Phase 2 |
| No Longer Available | Tazemetostat Expanded Access Program for Adults With Solid Tumors NCT03874455 | Epizyme, Inc. | — |